Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

UNR/CSDE1 Expression Is Critical to Maintain Invasive Phenotype of Colorectal Cancer through Regulation of c-MYC and Epithelial-to-Mesenchymal Transition.

Martinez-Useros J, Garcia-Carbonero N, Li W, Fernandez-Aceñero MJ, Cristobal I, Rincon R, Rodriguez-Remirez M, Borrero-Palacios A, Garcia-Foncillas J.

J Clin Med. 2019 Apr 25;8(4). pii: E560. doi: 10.3390/jcm8040560.

2.

Effect of Congruence Between Sound and Video on Heart Rate and Self-Reported Measures of Emotion.

Calderón S, Rincón R, Araujo A, Gantiva C.

Eur J Psychol. 2018 Aug 31;14(3):621-631. doi: 10.5964/ejop.v14i3.1593. eCollection 2018 Aug.

3.

A comprehensive study of calcific aortic stenosis: from rabbit to human samples.

Mourino-Alvarez L, Baldan-Martin M, Sastre-Oliva T, Martin-Lorenzo M, Maroto AS, Corbacho-Alonso N, Rincon R, Martin-Rojas T, Lopez-Almodovar LF, Alvarez-Llamas G, Vivanco F, Padial LR, de la Cuesta F, Barderas MG.

Dis Model Mech. 2018 Jun 19;11(6). pii: dmm033423. doi: 10.1242/dmm.033423.

4.

Potential role of new molecular plasma signatures on cardiovascular risk stratification in asymptomatic individuals.

Baldan-Martin M, Lopez JA, Corbacho-Alonso N, Martinez PJ, Rodriguez-Sanchez E, Mourino-Alvarez L, Sastre-Oliva T, Martin-Rojas T, Rincón R, Calvo E, Vazquez J, Vivanco F, Padial LR, Alvarez-Llamas G, Ruiz-Hurtado G, Ruilope LM, Barderas MG.

Sci Rep. 2018 Mar 19;8(1):4802. doi: 10.1038/s41598-018-23037-7.

5.

Recent advances and clinical insights into the use of proteomics in the study of atherosclerosis.

Mourino-Alvarez L, Baldan-Martin M, Rincon R, Martin-Rojas T, Corbacho-Alonso N, Sastre-Oliva T, Barderas MG.

Expert Rev Proteomics. 2017 Aug;14(8):701-713. doi: 10.1080/14789450.2017.1353912. Epub 2017 Jul 14. Review.

PMID:
28689450
6.

c-Jun N-Terminal Kinase Inactivation by Mitogen-Activated Protein Kinase Phosphatase 1 Determines Resistance to Taxanes and Anthracyclines in Breast Cancer.

Rincón R, Zazo S, Chamizo C, Manso R, González-Alonso P, Martín-Aparicio E, Cristóbal I, Cañadas C, Perona R, Lluch A, Eroles P, García-Foncillas J, Albanell J, Rovira A, Madoz-Gúrpide J, Rojo F.

Mol Cancer Ther. 2016 Nov;15(11):2780-2790. Epub 2016 Sep 6.

7.

Downregulation of microRNA-199b predicts unfavorable prognosis and emerges as a novel therapeutic target which contributes to PP2A inhibition in metastatic colorectal cancer.

Cristóbal I, Caramés C, Rincón R, Manso R, Madoz-Gúrpide J, Torrejón B, González-Alonso P, Rojo F, García-Foncillas J.

Oncotarget. 2017 Jun 20;8(25):40169-40180. doi: 10.18632/oncotarget.11174.

8.

Pyrosequencing-Based Assays for Rapid Detection of HER2 and HER3 Mutations in Clinical Samples Uncover an E332E Mutation Affecting HER3 in Retroperitoneal Leiomyosarcoma.

González-Alonso P, Chamizo C, Moreno V, Madoz-Gúrpide J, Carvajal N, Daoud L, Zazo S, Martín-Aparicio E, Cristóbal I, Rincón R, García-Foncillas J, Rojo F.

Int J Mol Sci. 2015 Aug 17;16(8):19447-57. doi: 10.3390/ijms160819447.

9.

Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer.

Aguilera Ó, González-Sancho JM, Zazo S, Rincón R, Fernández AF, Tapia O, Canals F, Morte B, Calvanese V, Orgaz JL, Niell N, Aguilar S, Freije JM, Graña O, Pisano DG, Borrero A, Martínez-Useros J, Jiménez B, Fraga MF, García-Foncillas J, López-Otín C, Lafarga M, Rojo F, Muñoz A.

Oncotarget. 2015 Mar 20;6(8):5903-17.

10.

PP2A inhibition determines poor outcome and doxorubicin resistance in early breast cancer and its activation shows promising therapeutic effects.

Rincón R, Cristóbal I, Zazo S, Arpí O, Menéndez S, Manso R, Lluch A, Eroles P, Rovira A, Albanell J, García-Foncillas J, Madoz-Gúrpide J, Rojo F.

Oncotarget. 2015 Feb 28;6(6):4299-314.

11.

Deregulation of the PP2A inhibitor SET shows promising therapeutic implications and determines poor clinical outcome in patients with metastatic colorectal cancer.

Cristóbal I, Rincón R, Manso R, Caramés C, Zazo S, Madoz-Gúrpide J, Rojo F, García-Foncillas J.

Clin Cancer Res. 2015 Jan 15;21(2):347-56. doi: 10.1158/1078-0432.CCR-14-0724. Epub 2014 Nov 11.

12.

Re: Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.

Cristóbal I, Rincón R, Manso R, Rojo F, García-Foncillas J.

J Natl Cancer Inst. 2014 Aug 18;106(8). pii: dju196. doi: 10.1093/jnci/dju196. Print 2014 Aug. No abstract available.

PMID:
25136032
13.

Hyperphosphorylation of PP2A in colorectal cancer and the potential therapeutic value showed by its forskolin-induced dephosphorylation and activation.

Cristóbal I, Rincón R, Manso R, Madoz-Gúrpide J, Caramés C, del Puerto-Nevado L, Rojo F, García-Foncillas J.

Biochim Biophys Acta. 2014 Sep;1842(9):1823-9. doi: 10.1016/j.bbadis.2014.06.032. Epub 2014 Jul 2.

14.

Deregulation of miR-200b, miR-200c and miR-429 indicates its potential relevant role in patients with colorectal cancer liver metastasis.

Cristóbal I, Rincón R, Manso R, Caramés C, Aguilera O, Madoz-Gurpide J, Rojo F, García-Foncillas J.

J Surg Oncol. 2014 Sep;110(4):484-5. doi: 10.1002/jso.23661. Epub 2014 Jun 10. No abstract available.

PMID:
24916918
15.

Potential involvement of protein phosphatase 2A in temsirolimus-mediated resensitization to cetuximab in colon cancer cells.

Cristóbal I, Manso R, Rincón R, Madoz-Gúrpide J, Caramés C, Rojo F, García-Foncillas J.

J Cancer Res Clin Oncol. 2014 Jul;140(7):1249-50. doi: 10.1007/s00432-014-1707-2. Epub 2014 May 15. No abstract available.

PMID:
24828260
16.

Up-regulation of c-Cbl suggests its potential role as oncogene in primary colorectal cancer.

Cristóbal I, Manso R, Rincón R, Caramés C, Madoz-Gúrpide J, Rojo F, García-Foncillas J.

Int J Colorectal Dis. 2014 May;29(5):641. doi: 10.1007/s00384-014-1839-5. Epub 2014 Feb 15. No abstract available.

PMID:
24525700
17.

PP2A inhibition is a common event in colorectal cancer and its restoration using FTY720 shows promising therapeutic potential.

Cristóbal I, Manso R, Rincón R, Caramés C, Senin C, Borrero A, Martínez-Useros J, Rodriguez M, Zazo S, Aguilera O, Madoz-Gúrpide J, Rojo F, García-Foncillas J.

Mol Cancer Ther. 2014 Apr;13(4):938-47. doi: 10.1158/1535-7163.MCT-13-0150. Epub 2014 Jan 21.

18.

Deficiency in p53 is required for doxorubicin induced transcriptional activation of NF-кB target genes in human breast cancer.

Dalmases A, González I, Menendez S, Arpí O, Corominas JM, Servitja S, Tusquets I, Chamizo C, Rincón R, Espinosa L, Bigas A, Eroles P, Furriol J, Lluch A, Rovira A, Albanell J, Rojo F.

Oncotarget. 2014 Jan 15;5(1):196-210.

Supplemental Content

Loading ...
Support Center